---Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy.

CONCLUSION: Transcriptomic profiling identifies patients with an excellent outcome without any systemic adjuvant therapy in clinically low-risk patients of the SweBCG91-RT and METABRIC cohorts. PMID: 31558478 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Tags: Clin Cancer Res Source Type: research